Latest News Feed

Press Release Sep 28, 2020
FSD Pharma Begins Phase 2 Clinical Trial to Evaluate FSD201 for the Treatment of Hospitalized COVID-19 Patients
Press Release Aug 31, 2020
FSD Pharma Announces Phase 2 Clinical Trial IND Filing with the FDA to Treat Patients with COVID-19
Press Release Aug 7, 2020
FSD Pharma Reports Second Quarter 2020 Financial Results
Press Release Aug 6, 2020
FSD Pharma Inc. Announces Closing of US $10 Million Registered Direct Offering to Institutional Investors
Press Release Jul 31, 2020
FSD Pharma Inc. Announces US$10 Million Registered Direct Offering
Press Release Jul 30, 2020
FSD Pharma Announces Decision to Surrender Health Canada Licenses for Subsidiary FV Pharma Inc.
Press Release Jul 13, 2020
FSD Pharma Announces US$20M At-The-Market Offering
Press Release Jun 22, 2020
FSD Pharma Reports Favorable Topline Results from Phase 1 First-in-Human Safety and Tolerability Study of Ultramicronized PEA